Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
Yasui-Furukori N, Muraoka H, Hasegawa N, Ochi S, Numata S, Hori H, Hishimoto A, Onitsuka T, Ohi K, Hashimoto N, Nagasawa T, Takaesu Y, Inagaki T, Tagata H, Tsuboi T, Kubota C, Furihata R, Iga JI, Iida H, Miura K, Matsumoto J, Yamada H, Watanabe K, Inada K, Shimoda K, Hashimoto R.
Yasui-Furukori N, et al. Among authors: ochi s.
Neuropsychopharmacol Rep. 2022 Mar;42(1):3-9. doi: 10.1002/npr2.12218. Epub 2021 Dec 2.
Neuropsychopharmacol Rep. 2022.
PMID: 34854260
Free PMC article.